A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWA
Not Applicable
- Conditions
- Atrial fibrillation
- Registration Number
- JPRN-UMIN000011830
- Lead Sponsor
- ASSAF-K steering committee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
Inappropriate patients considered by attending physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. clinical profiles of the patients 2. clinical status of treatments 3. outcome 3-1 survive or died and its cause (cardiac or cerebro-vascular, others) 3-2 cerebro-vascular events (cerebral infarction, intra-cranial bleeding, sequela: symptomatic or transient) 3-3 bleeding (Major or others) Major bleeding defined by the criteria of International Society on Thrombosis and Haemostasis.
- Secondary Outcome Measures
Name Time Method 1. Relationship between efficacy/safety and treatments 2. comparison between pharmacological treatments regarding outcome